2000 Participants Needed

Bereavement Support Strategies for Grief After Child Loss

Recruiting at 7 trial locations
KM
CS
Overseen ByCarolyn Sutter, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to find better ways to support parents grieving the sudden or unexpected loss of a child, such as through suicide or overdose. Researchers will compare two strategies: a program called CommunityRx-Bereavement and general bereavement support information. The goal is to determine which method helps parents cope more effectively during this difficult time. Parents or caregivers who have experienced such a loss and have interacted with a medical examiner or coroner in certain Illinois counties might be eligible to participate.

As an unphased trial, this study offers participants the opportunity to contribute to developing new support strategies for grieving parents.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that these bereavement support strategies are safe for grieving parents?

Research has shown that both CommunityRx-Bereavement (CRx-B) and General Bereavement Support Information (GBSI) receive positive feedback from participants. These programs aim to support parents after the loss of a child. CommunityRx-Bereavement includes a Grief Navigator who contacts parents with information and support, while General Bereavement Support offers more general assistance.

Previous studies have not reported any major safety issues or negative effects with either approach, indicating that these programs are safe for participants. They are designed to provide emotional support, which typically involves very low physical risk.12345

Why are researchers excited about this trial?

Researchers are excited about the trial on bereavement support strategies because it explores innovative approaches to help individuals coping with the profound grief of losing a child. The CommunityRx-Bereavement (CRx-B) program is unique because it tailors support resources to the specific needs of each bereaved individual, potentially offering more personalized care than standard bereavement support, which often involves general counseling or support groups. Meanwhile, the General Bereavement Support Information (GBSI) serves as an active comparator, providing comprehensive information that helps participants understand and manage their grief. This trial aims to reveal which approach better supports healing and adjustment, offering hope for more effective coping strategies in the future.

What evidence suggests that this trial's treatments could be effective for grief after child loss?

Research has shown that the CommunityRx-Bereavement (CRx-B) program, a treatment in this trial, is a new, proven method to help grieving parents. It is easy to use and can be expanded to assist many people. The program connects parents with resources to support them after the unexpected or traumatic loss of a child. In contrast, the General Bereavement Support Information (GBSI), another treatment arm in this trial, offers more traditional support by providing general advice and resources for dealing with grief. This trial tests both approaches to determine which one better helps parents cope with their loss.13678

Who Is on the Research Team?

KM

Kelly Michelson, MD, MPH

Principal Investigator

Lurie Children's Hospital

SL

Stacy Lindau, MD, MAPP

Principal Investigator

University of Chicago

Are You a Good Fit for This Trial?

This trial is for parents or legal caregivers who have lost a child under 25 years old to unexpected or traumatic events, and are referred by medical examiners. Participants must be able to communicate in English or Spanish and give permission to the ME for referral. Those unable to understand these languages or under 18 cannot join.

Inclusion Criteria

I am the parent or legal caregiver of a minor under 25 involved in a medical examiner case.
Parents or legal caregivers who provide permission to the ME to be referred to Missing Pieces
Parent or legal caregivers who are referred to Missing Pieces by a ME

Exclusion Criteria

Parents or legal caregivers unable to read or communicate in English or Spanish
I am a parent or caregiver under 18.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive either CommunityRx-Bereavement (CRx-B) or General Bereavement Support Information (GBSI) to support parents after a child's unexpected or traumatic death

6.5 months
Surveys conducted approximately 6.5 months after child's death

Follow-up

Participants are monitored for self-efficacy in finding resources and symptoms of complicated grief

6.5 months

What Are the Treatments Tested in This Trial?

Interventions

  • CommunityRx-Bereavement
  • General Bereavement Support Information
Trial Overview The study compares two support strategies for grieving parents post-child loss: General Bereavement Support Information versus CommunityRx-Bereavement, aiming to address the healthcare system's gap in aiding families during such crises.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: CommunityRx-Bereavement (CRx-B)Experimental Treatment1 Intervention
Group II: General Bereavement Support Information (GBSI)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ann & Robert H Lurie Children's Hospital of Chicago

Lead Sponsor

Trials
275
Recruited
5,182,000+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+

University of Chicago

Collaborator

Trials
1,086
Recruited
844,000+

Missing Pieces, a program of the HAP Foundation

Collaborator

Trials
1
Recruited
2,000+

Published Research Related to This Trial

A systematic review of 74 studies on bereavement interventions found that while pharmacotherapy is effective for treating bereavement-related depression, other therapeutic approaches lack consistent evidence of benefit.
The review highlights significant challenges in establishing effective bereavement care, including variability in study designs and insufficient reporting, which hinder the development of evidence-based recommendations.
Bereavement care interventions: a systematic review.Forte, AL., Hill, M., Pazder, R., et al.[2019]
A systematic review of bereavement support programs for parents who lost a child found no overall benefit from these interventions, based on three controlled studies from 1990 to 2001.
However, highly distressed mothers showed significant reductions in psychological symptoms and marital dysfunction, suggesting that targeted support may be more effective for certain individuals rather than a one-size-fits-all approach.
Do interventions make a difference to bereaved parents? A systematic review of controlled studies.Rowa-Dewar, N.[2018]
Bereavement support is crucial in critical care settings, as it can significantly impact families after the loss of a loved one in the ICU.
The review suggests that effective bereavement programs should include tangible resources like brochures and memory-making activities, and utilize a bereavement risk assessment tool to tailor support to families' specific needs.
Bereavement Care in the Adult Intensive Care Unit: Directions for Practice.Erikson, A., McAdam, J.[2021]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40436312/
The Grief Navigation Trial: A multi-site pragmatic ...This comparative effectiveness trial will test two strategies that help parents and caregivers find support after traumatic or unexpected pediatric death.
The Grief Navigation Trial: A multi-site pragmatic ...This comparative effectiveness trial will test two strategies that help parents and caregivers find support after traumatic or unexpected pediatric death.
Study Details | NCT06136260 | The Grief Navigation Trial: ...Study Overview · CommunityRx-Bereavement (CRx-B), an evidence- and theory-based, low intensity, highly scalable intervention, and · General bereavement support ...
Bereavement Support Strategies for Grief After Child LossTrial Overview The study compares two support strategies for grieving parents post-child loss: General Bereavement Support Information versus CommunityRx- ...
P3.E097: Study Protocol for the Missing Pieces TrialOur aim was to compare the effectiveness of two interventions provided by Missing Pieces: (1) CommunityRx-Bereavement ... grief support organizations.
A Comparison of Two Interventions to Support Parents ...CommunityRx-Bereavement (CRx-B), an evidence- and theory-based, low intensity, highly scalable intervention, and. General bereavement support ...
A multi-site pragmatic comparative effectiveness trial of two ...This comparative effectiveness trial will test two strategies that help parents and caregivers find support after traumatic or unexpected pediatric death.
Parents who lose children to traumatic deaths often face ...This clinical trial evaluates two interventions: CommunityRx-Bereavement and General Bereavement Support. In a randomized trial, parents will be ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security